Oracle’s 3rd Annual Drug Development and Safety Forum 2009- India

Oracle’s 3rd Annual Drug Development and Safety Forum 2009 October 21 – 22, 2009 Oracle invites you to the 2009 Drug Development and Safety Forum At this forum we will be discussing important topics and issues facing the Indian Pharmaceutical Biotechnology, and CRO industry. This event will be highlighted by presentations from key industry thought [...]

Oracle and Inforsense Integrating Clinical And Genomics Data for Personalized Medicine

BIO-IT WORLD COVERAGE ON INTEGRATING CLINICAL AND GENOMICS DATA AND PLATFORMS FOR PERSONALIZED MEDICINE The March-April 2009 issue of Bio-IT World features Dana-Farber Cancer Institute cover story on integrating clinical and genomics data including details on the organization’s work with Oracle and InforSense, as well as a byline article on platforms for personalized medicine by [...]

Oracle announced it agreed to acquire Relsys

On March 23, 2009, Oracle announced it agreed to acquire Relsys, a leading provider of drug safety, risk management and analytics applications for the health sciences industry. Relsys’s best-in-class solutions support adverse event reporting, risk management and drug safety analysis for pharmaceutical, biotechnology, contract research organizations and medical device companies worldwide. More details on Oracle [...]